FDG PET/CT imaging for prognosis of metastatic non-iodine avid differentiated thyroid cancer. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract does not include a ...
A panelist discusses how a large propensity score–matched analysis of 1300 patients aged 60-75 found similar all-cause mortality between intensive chemotherapy and azacitidine plus venetoclax, but ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results